Fluorexetamine (3'-Fluoro-2-oxo-PCE, 3-FXE) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects. It has reportedly been sold over the internet since around 2017, though has remained relatively uncommon.[1]

Fluorexetamine
Legal status
Legal status
Identifiers
  • 2-(ethylamino)-2-(3-fluorophenyl)cyclohexan-1-one
PubChem CID
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H18FNO
Molar mass235.302 g·mol−1
3D model (JSmol)
  • CCNC1(CCCCC1=O)c1cccc(F)c1
  • InChI=1S/C14H18FNO/c1-2-16-14(9-4-3-8-13(14)17)11-6-5-7-12(15)10-11/h5-7,10,16H,2-4,8-9H2,1H3
  • Key:FCETYWCLCUZFJI-UHFFFAOYSA-N

In April 2023 it was revealed by DrugsData.org that all their previously analyzed samples of fluorexetamine actually contained 2'-Fluoro-2-oxo-PCE (2-FXE, also known as CanKet) rather than 3'-Fluoro-2-oxo PCE (3-FXE). This was confirmed by a newly available reference standard for 2-FXE.[2] Similar misidentification may have occurred in other laboratories.

See also

edit

References

edit
  1. ^ Wallach J, Brandt SD (2018). "1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances". Handbook of Experimental Pharmacology. 252: 305–352. doi:10.1007/164_2018_148. ISBN 978-3-030-10560-0. PMID 30196446.
  2. ^ Erowid, DrugsData org /. "DrugsData.org (was EcstasyData): Test Details : Result #15191 - White Crystals, 15191". www.drugsdata.org. Retrieved 2023-12-02.